An evaluation of 10 men with prostate cancer found 90% had microplastics in their tumors, with concentrations more than double that found in surrounding benign prostate tissue.The data, which will be ...

In tissue samples collected from patients with prostate cancer, microplastics and nanoplastics (MNPs) were present in almost every one, according to a small proof-of-concept study. Among 10 patients ...

AI is changing how cancer care decisions are made, empowering patients and doctors to make more personalized choices. For ...

AI in Pathology Market OverviewThe global AI in pathology market is anticipated to witness robust expansion, growing at an ...

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

A novel, cooled laser focal therapy (cLFT) exhibits high treatment success for localized prostate cancer (PCa), according to a study published online Jan. 28 in ...

The field of pathology is rapidly evolving toward the integration of molecular and cellular levels, immunology, and digital advances to better understand ...

AI in oncology is poised to revolutionize cancer care through early, accurate detection, and personalized treatment, driven ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...

SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the U.S. Food and Drug ...

It’s among the most common cancers affecting older men. But a diagnosis today isn’t always what it seems. By David Dodge An estimated one in eight men will be diagnosed with prostate cancer in their ...